Brief: Sesen Bio Says Restructuring Plan Includes Incremental Reduction In Workforce
July 20 (Reuters) - Sesen Bio Inc SESN.O :
* SESEN BIO INC - CO'S EARLIER ANNOUNCED RESTRUCTURING PLAN
INCLUDES AN INCREMENTAL REDUCTION IN THE COMPANY’S WORKFORCE
* SESEN BIO - CO CURRENTLY ESTIMATES THAT IT WILL INCUR IN
THE Q3
& Q4 OF 2022 SEVERANCE & OTHER EMPLOYEE-RELATED COSTS OF
APPROXIMATELY $8 MILLION.
* SESEN BIO - EXPECTS TO INCUR ONE-TIME CASH COSTS
ASSOCIATED
WITH THE TERMINATION OF CERTAIN CONTRACTS AND OTHER ACTIVITIES
UNDER RESTRUCTURING PLAN
Further company coverage: SESN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary